A detailed history of Intrust Bank Na transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Intrust Bank Na holds 19,785 shares of BMY stock, worth $1.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
19,785
Previous 24,204 18.26%
Holding current value
$1.1 Million
Previous $1.31 Million 37.42%
% of portfolio
0.09%
Previous 0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $177,864 - $234,162
-4,419 Reduced 18.26%
19,785 $821,000
Q1 2024

May 09, 2024

BUY
$47.98 - $54.4 $109,586 - $124,249
2,284 Added 10.42%
24,204 $1.31 Million
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $78,101 - $93,196
-1,611 Reduced 6.85%
21,920 $1.12 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $153,119 - $171,210
-2,645 Reduced 10.1%
23,531 $1.37 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $239,039 - $265,416
-3,752 Reduced 12.54%
26,176 $1.67 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $55,984 - $63,499
-852 Reduced 2.77%
29,928 $2.07 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $5,204 - $6,162
76 Added 0.25%
30,780 $2.21 Million
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $477 - $282,233
-3,673 Reduced 10.68%
30,704 $2.18 Million
Q2 2022

Aug 16, 2022

BUY
$72.62 - $79.98 $224,541 - $247,298
3,092 Added 9.88%
34,377 $2.65 Million
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $528,236 - $633,402
8,592 Added 37.86%
31,285 $2.29 Million
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $15,445 - $18,005
288 Added 1.29%
22,693 $1.42 Million
Q3 2021

Nov 04, 2021

SELL
$59.17 - $69.31 $86,624 - $101,469
-1,464 Reduced 6.13%
22,405 $1.33 Million
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $58,628 - $63,846
-947 Reduced 3.82%
23,869 $1.6 Million
Q1 2021

Jun 02, 2021

SELL
$59.34 - $66.74 $266,317 - $299,529
-4,488 Reduced 15.32%
24,816 $1.57 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $64,437 - $73,019
-1,116 Reduced 3.67%
29,304 $1.82 Million
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $12,634 - $14,000
-220 Reduced 0.72%
30,420 $1.83 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $89,740 - $104,915
1,637 Added 5.64%
30,640 $1.8 Million
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $104,956 - $152,526
2,262 Added 8.46%
29,003 $1.62 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $395,697 - $516,151
8,041 Added 43.0%
26,741 $1.72 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $9,666 - $11,460
226 Added 1.22%
18,700 $948,000
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $86,696 - $95,867
1,943 Added 11.75%
18,474 $838,000
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $70,206 - $83,712
-1,556 Reduced 8.6%
16,531 $789,000
Q4 2018

Feb 06, 2019

BUY
$48.76 - $63.23 $73,237 - $94,971
1,502 Added 9.06%
18,087 $940,000
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $717 - $809
13 Added 0.08%
16,585 $1.03 Million
Q2 2018

Aug 08, 2018

SELL
$50.53 - $62.98 $107,932 - $134,525
-2,136 Reduced 11.42%
16,572 $918,000
Q1 2018

May 03, 2018

SELL
$59.92 - $68.98 $22,649 - $26,074
-378 Reduced 1.98%
18,708 $1.18 Million
Q4 2017

Feb 08, 2018

SELL
$59.94 - $65.35 $34,585 - $37,706
-577 Reduced 2.93%
19,086 $1.17 Million
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $1.09 Million - $1.25 Million
19,663
19,663 $1.25 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.